Causes, Consequences, and Treatment of Hyperlipidemia in Patients with Renal Disease

[1]  Y. Bar-Khayim,et al.  Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels. , 1990, Kidney international.

[2]  C. Packard,et al.  Low-density lipoprotein metabolism in the nephrotic syndrome. , 1990, Metabolism: clinical and experimental.

[3]  R. Moore,et al.  The effect of the American Heart Association step one diet on hyperlipidemia following renal transplantation. , 1990, Transplantation.

[4]  B. Kasiske,et al.  The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  B. Kasiske,et al.  Lovastatin treatment of hypercholesterolemia in renal transplant recipients. , 1990, Transplantation.

[6]  J. Awada,et al.  Effects of fish oil rich in polyunsaturated fatty acids on hyperlipidemia of hemodialysis patients. , 1989, Kidney international. Supplement.

[7]  H. Tyroler,et al.  Overview of clinical trials of cholesterol lowering in relationship to epidemiologic studies. , 1989, The American journal of medicine.

[8]  E. Janus,et al.  Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis. , 1989, Atherosclerosis.

[9]  A. Cheung,et al.  Treatment of nephrotic hyperlipoproteinemia with gemfibrozil. , 1989, Kidney international.

[10]  E. Vilella,et al.  Low density lipoprotein metabolism in rats with puromycin aminonucleoside-induced nephrotic syndrome. , 1989, Metabolism: clinical and experimental.

[11]  D. Illingworth,et al.  Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  C. Blum,et al.  The hyperlipidemia of the nephrotic syndrome. , 1985, The American journal of medicine.

[13]  R. Hené,et al.  EFFECTS OF SIMVASTATIN AND CHOLESTYRAMINE ON LIPOPROTEIN PROFILE IN HYPERLIPIDAEMIA OF NEPHROTIC SYNDROME , 1988, The Lancet.

[14]  P. Daloze,et al.  Rapid improvement of hyperlipidemia in kidney transplant patients with a multifactorial hypolipidemic diet. , 1988, Transplantation proceedings.

[15]  M. Middeke,et al.  Review of major intervention studies in hypertension and hyperlipidemia: focus on coronary heart disease. , 1988, American heart journal.

[16]  H. Oksa,et al.  Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: the Finnish Multicenter Study. , 1988, The American journal of cardiology.

[17]  M. Quiñones,et al.  Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients. , 1988, JAMA.

[18]  B. Kasiske.  Risk factors for accelerated atherosclerosis in renal transplant recipients. , 1988, The American journal of medicine.

[19]  S. Grundy,et al.  Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism. , 1988, Kidney international.

[20]  B. Kasiske,et al.  Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. , 1988, Kidney international.

[21]  G. Maschio,et al.  Effect of protein-restricted diet on serum lipids and atherosclerosis risk factors in patients with chronic renal failure. , 1988, Clinical nephrology.

[22]  J. Rogers,et al.  Effects of dietary fish oil on serum lipids and blood coagulation in peritoneal dialysis patients. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  G. Duggin,et al.  The effect of food and cholestyramine on the absorption of cyclosporine in cardiac transplant recipients. , 1988, Transplantation proceedings.

[24]  B. Kasiske,et al.  Pharmacologic Treatment of Hyperlipidemia Reduces Glomerular Injury in Rat 5/6 Nephrectomy Model of Chronic Renal Failure , 1988, Circulation research.

[25]  S. Grundy,et al.  Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation. , 1988, The New England journal of medicine.

[26]  D. Illingworth,et al.  Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin. , 1988, The New England journal of medicine.

[27]  G. Camejo,et al.  Lipoprotein structural abnormalities in chronic renal failure with and without hemodialysis. , 1988, Biomedica biochimica acta.

[28]  W. März,et al.  Lipoproteins and apolipoproteins during the progression of chronic renal disease. , 1988, Nephron.

[29]  Daniel Steinberg,et al.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.

[30]  P. Gartside,et al.  High-density lipoprotein apolipoprotein AI and AII turnover in moderate and severe proteinuria. , 1988, Nephron.

[31]  J. Mann,et al.  Adverse effect of cyclosporin on plasma cholesterol in renal transplant recipients. , 1988, Nephrology, Dialysis and Transplantation.

[32]  R. Wilkinson,et al.  OUTCOME IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS AND HAEMODIALYSIS: 4-YEAR ANALYSIS OF A PROSPECTIVE MULTICENTRE STUDY , 1987, The Lancet.

[33]  W. Caselmann,et al.  Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[34]  B. Kasiske,et al.  Persistent Hyperlipidemia in Renal Transplant Patients , 1987, Medicine.

[35]  R. Havel.  Lipid transport function of lipoproteins in blood plasma. , 1987, The American journal of physiology.

[36]  T. Hutchinson,et al.  Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis. , 1987, Atherosclerosis.

[37]  A. Pasternack,et al.  Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure. , 1987, Clinical nephrology.

[38]  W. Ettinger,et al.  Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids. , 1987, Atherosclerosis.

[39]  R. Lowry,et al.  Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors. , 1987, Transplantation proceedings.

[40]  M. Fujita,et al.  Effect of probucol on hyperlipidemia in patients with nephrotic syndrome. , 1987, Nephron.

[41]  B. Lindholm,et al.  Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis. , 2009, Acta medica Scandinavica.

[42]  C. Blum,et al.  Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  N. Rifai.  Lipoproteins and apolipoproteins. Composition, metabolism, and association with coronary heart disease. , 1986, Archives of pathology & laboratory medicine.

[44]  L. Hunt,et al.  Serum and urinary high density lipoproteins in glomerular disease with proteinuria. , 1986, Kidney international.

[45]  C. Fielding,et al.  Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. , 1986, The Journal of clinical investigation.

[46]  J. Walls,et al.  Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. , 1986, British medical journal.

[47]  V. Parsons,et al.  Fish oil modifies lipids and reduces platelet aggregability in haemodialysis patients. , 1986, Nephron.

[48]  S. Taskar,et al.  Study of hyperlipidemia in adults with nephrotic syndrome. , 1985, Journal of postgraduate medicine.

[49]  E. Muls,et al.  Lipoprotein distribution and composition in the human nephrotic syndrome. , 1985, Atherosclerosis.

[50]  K. Asayama,et al.  Lipid Profiles and Lipase Activities in Children and Adolescents with Chronic Renal Failure Treated Conservatively or with Hemodialysis or Transplantation , 1984, Pediatric Research.

[51]  Z. Varghese,et al.  Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients. , 1984, Kidney international.

[52]  J. Walls,et al.  The effect of renal transplantation with a minimal steroid regime on uraemic hypertriglyceridaemia. , 1984, The Quarterly journal of medicine.

[53]  P. Grützmacher,et al.  Early changes of plasma lipid status and glucose tolerance during the course of chronic renal failure. , 1984, Contributions to nephrology.

[54]  J. Sadler,et al.  Patient profile and effect of dietary therapy on post-transplant hyperlipidemia. , 1983, Kidney international. Supplement.

[55]  M. Taskinen,et al.  Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome. , 1983, The Journal of clinical endocrinology and metabolism.

[56]  T. Starzl,et al.  Causes of death after kidney transplantation. , 1983, JAMA.

[57]  J. M. Ramos,et al.  Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis. , 1983, Nephron.

[58]  P. Nestel,et al.  Increased lipoprotein-remnant formation in chronic renal failure. , 1982, The New England journal of medicine.

[59]  R. Luke,et al.  Effect of alternate-day prednisone on plasma lipids in renal transplant recipients. , 1982, Kidney international.

[60]  T. Golper,et al.  Impaired renal mevalonate metabolism in nephrotic syndrome: a stimulus for increased hepatic cholesterogenesis independent of GFR and hypoalbuminemia. , 1982, Metabolism: clinical and experimental.

[61]  Z. Varghese,et al.  Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenetic roles of triglyceride production and triglyceride removal. , 1982, Clinical nephrology.

[62]  Z. Varghese,et al.  Plasma lecithin-cholesterol acyltransferase activities in uraemic patients. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[63]  R. Goldberg,et al.  The role of diet in the pathogenesis and control of hyperlipidemia after renal transplantation. , 1981, Clinical nephrology.

[64]  L. Carlson,et al.  Increased frequency of late pre‐β lipoproteins (LP β) in isolated serum very low density lipoproteins in uraemia , 1980 .

[65]  L. Simons,et al.  Impaired plasma triglyceride clearance as a feature of both uremic and posttransplant triglyceridemia. , 1980, Kidney international.

[66]  G. Reaven,et al.  An inquiry into the mechanism of hypertriglyceridemia in patients with chronic renal failure. , 1980, The American journal of clinical nutrition.

[67]  K. Jung,et al.  Lecithin: cholesterol acyltransferase activity, HDL-cholesterol and apolipoprotein A in serum of patients undergoing chronic haemodialysis. , 1980, Enzyme.

[68]  D. Sherrard,et al.  Chronic clofibrate therapy in maintenance hemodialysis patients. , 1980, Nephron.

[69]  W. Riesen,et al.  LIPOPROTEIN METABOLISM IN NEPHROTIC SYNDROME IN CHILDHOOD , 1980, Pediatric Research.

[70]  A. Goldberg,et al.  Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis. , 1979, The New England journal of medicine.

[71]  R. Moore,et al.  Hyperlipidaemia Following Renal Transplantation , 1979 .

[72]  R. Jarrett,et al.  DOES THE NEPHROTIC SYNDROME INCREASE THE RISK OF CARDIOVASCULAR DISEASE? , 1979, The Lancet.

[73]  M. Karvonen,et al.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. , 1979, British heart journal.

[74]  I. Staprans,et al.  Apoprotein composition of plasma lipoproteins in uremic patients on hemodialysis. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[75]  C. Chaimovitz,et al.  Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis. , 1978, The New England journal of medicine.

[76]  A. K. Saxena,et al.  Relationship of plasma lipids to renal function and length of time on maintenance hemodialysis. , 1978, The American journal of clinical nutrition.

[77]  D. Grafnetter,et al.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. , 1978, British heart journal.

[78]  J. Mann,et al.  Treatment of hyperlipidaemia in patients on chronic haemodialysis. , 1978, British medical journal.

[79]  A. Sheil,et al.  Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis. , 1977, The Quarterly journal of medicine.

[80]  G. Reaven,et al.  Reduction of plasma triglycerides by diet in subjects with chronic renal failure. , 1977, Kidney international.

[81]  N. Gilboa.  Letter: Incidence of coronary heart disease associated with nephrotic syndrome. , 1976, The Medical journal of Australia.

[82]  V. Manninen,et al.  Hypolipidæmic Action of Gemfibrozil in Adult Nephrotics , 1976, Proceedings of the Royal Society of Medicine.

[83]  F. Scheler,et al.  CLOFIBRATE-INDUCED MYOPATHY SYNDROME , 1976, The Lancet.

[84]  A. Pierides,et al.  CLOFIBRATE-INDUCED MUSCLE DAMAGE IN PATIENTS WITH CHRONIC RENAL FAILURE , 1975, The Lancet.

[85]  White Gb,et al.  Letter: A non-specific inhibitor of rubella haemagglutinin. , 1975 .

[86]  A. Sheil,et al.  Deaths from Occlusive Arterial Disease in Renal Allograft Recipients , 1974, British medical journal.

[87]  G. Schapel,et al.  INCREASED INCIDENCE OF CORONARY HEART DISEASE ASSOCIATED WITH COMBINED ELEVATION OF SERUM TRIGLYCERIDE AND CHOLESTEROL CONCENTRATIONS IN THE NEPHROTIC SYNDROME IN MAN , 1974, The Medical journal of Australia.

[88]  B. Scribner,et al.  Accelerated atherosclerosis in prolonged maintenance hemodialysis. , 1974, The New England journal of medicine.

[89]  H. Mcdevitt,et al.  Adrenocortical steroid treatment of rheumatic diseases. Effects on lipid metabolism. , 1973, Archives of internal medicine.

[90]  E. Lowrie,et al.  Survival of patients undergoing chronic hemodialysis and renal transplantation. , 1973, The New England journal of medicine.

[91]  G. Berlyne,et al.  Ischaemic heart-disease as a complication of nephrotic syndrome. , 1969, Lancet.

[92]  Todd Rm,et al.  Infant feeding with SMA. Further observations. , 1965 .

[93]  Graham-Stewart Cw.  TERMINATION OF PREGNANCY ON PSYCHIATRIC GROUNDS. , 1964 .

[94]  C. Janeway,et al.  Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins. , 1958, The Journal of clinical investigation.

[95]  W. R. Brain,et al.  Malnutrition and the nervous system. , 1947, Lancet.